Cefoxitin-Serum Creatinine Interference in a Patient With Nontuberculous

Authors

Dan Wang, Beaumont Health
Anthony J Emanuel
Ron R Neyens
Eugene Bakharev
Nikolina Babic

Document Type

Article

Publication Date

8-2021

Publication Title

Journal of pharmacy practice

Abstract

Cefoxitin is a second-generation cephamycin antibiotic, which at concentrations ≥100 µg/mL is known to modestly interfere, for up to 2 hours post-infusion, with serum creatinine measurement via the traditional Jaffe-based assay. We report a case of a severe serum creatinine elevation while utilizing cefoxitin as a component of an antimicrobial regimen in a critically ill patient with

Volume

34

Issue

4

First Page

658

Last Page

661

Recommended Citation

Wang D, Emanuel AJ, Neyens RR, Bakharev E, Babic N. Cefoxitin-Serum Creatinine Interference in a Patient With Nontuberculous Mycobacteria Ventriculomeningitis. J Pharm Pract. 2021 Aug;34(4):658-661. doi: 10.1177/0897190020921613. Epub 2020 Apr 30. PMID: 32351174.

DOI

10.1177/0897190020921613

ISSN

1531-1937

PubMed ID

32351174